Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
Animesh Pardanani, Terra L. Lasho, Rebecca R. Laborde, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1870-1873
Open Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2584
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
G-CSF and GM-CSF in Neutropenia
Hrishikesh Mehta, Michael Malandra, Seth J. Corey
The Journal of Immunology (2015) Vol. 195, Iss. 4, pp. 1341-1349
Open Access | Times Cited: 318
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
Nature Genetics (2013) Vol. 45, Iss. 8, pp. 942-946
Open Access | Times Cited: 248
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
Ayalew Tefferi, J. Thiele, Alessandro M. Vannucchi, et al.
Leukemia (2014) Vol. 28, Iss. 7, pp. 1407-1413
Open Access | Times Cited: 214
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox, et al.
Blood (2014) Vol. 123, Iss. 17, pp. 2645-2651
Open Access | Times Cited: 201
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo, Manja Meggendorfer, Stephan Hütter, et al.
Blood (2020) Vol. 136, Iss. 16, pp. 1851-1862
Open Access | Times Cited: 151
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 143
Disease evolution and outcomes in familial AML with germline CEBPA mutations
Kiran Tawana, Jun Wang, Aline Renneville, et al.
Blood (2015) Vol. 126, Iss. 10, pp. 1214-1223
Open Access | Times Cited: 178
Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies
Pankaj Dwivedi, Kenneth D. Greis
Experimental Hematology (2016) Vol. 46, pp. 9-20
Open Access | Times Cited: 134
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified
Sa A. Wang, Wayne Tam, Albert G. Tsai, et al.
Modern Pathology (2016) Vol. 29, Iss. 8, pp. 854-864
Open Access | Times Cited: 120
JAK2 activation by growth hormone and other cytokines
Michael J. Waters, Andrew J. Brooks
Biochemical Journal (2015) Vol. 466, Iss. 1, pp. 1-11
Open Access | Times Cited: 119
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
Angela G. Fleischman, Julia E. Maxson, Samuel B. Luty, et al.
Blood (2013) Vol. 122, Iss. 22, pp. 3628-3631
Open Access | Times Cited: 113
Pathogenesis of myeloproliferative neoplasms
Radek C. Skoda, Adrian Duek, Jean Grisouard
Experimental Hematology (2015) Vol. 43, Iss. 8, pp. 599-608
Open Access | Times Cited: 106
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia
Manja Meggendorfer, T. Haferlach, Tamara Alpermann, et al.
Haematologica (2014) Vol. 99, Iss. 12, pp. e244-e246
Open Access | Times Cited: 103
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal, Nicholas C.P. Cross, E. Padron, et al.
Haematologica (2015) Vol. 100, Iss. 9, pp. 1117-1130
Open Access | Times Cited: 98
Genomics of chronic neutrophilic leukemia
Julia E. Maxson, Jeffrey W. Tyner
Blood (2016) Vol. 129, Iss. 6, pp. 715-722
Open Access | Times Cited: 93
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T. Dao, Jason Gotlib, Michael M.N. Deininger, et al.
Journal of Clinical Oncology (2019) Vol. 38, Iss. 10, pp. 1006-1018
Open Access | Times Cited: 93
MDS overlap disorders and diagnostic boundaries
Tiffany Tanaka, Rafael Bejar
Blood (2019) Vol. 133, Iss. 10, pp. 1086-1095
Open Access | Times Cited: 80
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Gonzalo Carreño‐Tarragona, Alberto Álvarez‐Larrán, Claire Harrison, et al.
Blood Advances (2023) Vol. 7, Iss. 9, pp. 1672-1681
Open Access | Times Cited: 25
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 7, pp. 1360-1387
Closed Access | Times Cited: 13
Light chain amyloidosis: the heart of the problem
Giampaolo Merlini, Giovanni Palladini
Haematologica (2013) Vol. 98, Iss. 10, pp. 1492-1495
Open Access | Times Cited: 91
ASXL1 mutations are frequent and prognostically detrimental in CSF3R‐mutated chronic neutrophilic leukemia
Michelle A. Elliott, Animesh Pardanani, Curtis A. Hanson, et al.
American Journal of Hematology (2015) Vol. 90, Iss. 7, pp. 653-656
Open Access | Times Cited: 86
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. Deininger, Jeffrey W. Tyner, Éric Solary
Nature reviews. Cancer (2017) Vol. 17, Iss. 7, pp. 425-440
Closed Access | Times Cited: 76
Page 1 - Next Page

Scroll to top